Enlivex Ltd. Ordinary Shares (ENLV)

About ENLV

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

www.enlivex.com/

Fundamentals

Market cap

$33.33M

P/E (trailing)

0.02

P/E (forward)

—

EPS (trailing)

$149.75

Dividend yield

—

Beta

1.32

Avg. volume

—

Enlivex Ltd. Ordinary Shares Competitors

Chosen by industry and closest market cap.

• ENLV

  Enlivex Ltd. Ordinary Shares

  $1.35

  ▼ 8.47%
  Market cap $33.33MP/E 0.02
  $1.35$27.15
• LTRN

  Lantern Pharma Inc. Common Stock

  $2.08

  ▼ 3.70%
  Market cap $35.47MP/E —
  $1.11$4.7
• NNVC

  NanoViricides Inc. Common Stock

  $1.24

  ▼ 3.12%
  Market cap $35.56MP/E —
  $0.85$2.23
• BCTX

  BriaCell Therapeutics Corp. Common Shares

  $3.73

  ▲ 0.54%
  Market cap $30.01MP/E —
  $3.68$20.4
• IXHL

  Incannex Healthcare Inc. Common Stock

  $3.61

  ▼ 2.17%
  Market cap $37.21MP/E —
  $2.49$20.64
• ACTU

  Actuate Therapeutics Inc. Common stock

  $1.67

  ▼ 1.18%
  Market cap $29.43MP/E —
  $0.9$9.22
• APLM

  Apollomics Inc. Class A Ordinary Shares

  $26.6

  ▲ 1.14%
  Market cap $37.33MP/E —
  $3.66$42.12

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Thursday's After-Market Session
  Benzinga · 8/27/2026
• 12 Health Care Stocks Moving In Friday's After-Market Session
  Benzinga · 8/21/2026
• HC Wainwright & Co. Maintains Buy on Enlivex, Raises Price Target to $80
  Benzinga · 8/3/2026